NIGERIA PERSPECTIVE

Abuja, May 27, 2026. Nigeria has not yet recorded a single Ebola case, but preventive action is already underway. The Pharmaceutical Society of Nigeria (PSN) issued a national emergency directive on Saturday, ordering pharmacists and community pharmacies across all 36 federal states and the Federal Capital Territory to immediately activate their infection surveillance and prevention protocols.

The alert follows the declared outbreak in eastern Democratic Republic of Congo, where more than 900 suspected cases have been reported, compounded by reduced international aid flows, attacks on health centers, and growing public distrust of medical teams. Neighboring Uganda is also affected, prompting Africa CDC to place ten African countries under heightened surveillance.

"Community pharmacies are often the first point of contact for individuals presenting early symptoms," said Ayuba Ibrahim Tanko, president of the PSN, in the notice circulated to members. "Pharmacists across all 36 states and within the FCT must maintain a high index of suspicion." The society warns against self-medication and calls for immediate isolation and reporting of any suspected case, emphasizing that pharmacists are "among the first health professionals to encounter potential cases".

Meanwhile, Jean Kaseya, director of Africa Centres for Disease Control and Prevention (Africa CDC), has identified ten African countries at risk of cross-border transmission: Angola, Burundi, Central African Republic, Republic of Congo, Ethiopia, Kenya, Rwanda, South Sudan, Tanzania, and Zambia. Nigeria does not appear on this official list, which underscores each nation's distinct vulnerability based on its regional connectivity, yet Abuja chooses to act proactively rather than wait to be added.

The health coordinating minister confirmed that no cases have been detected on Nigerian soil, yet collective memory of past epidemics—notably the successful management of the 2014 Ebola outbreak—shapes current decision-making. Nigeria demonstrated then its capacity to contain spread quickly through rapid resource mobilization. This experience now informs a posture of anticipatory vigilance rather than reactive response.

Nigeria's approach also reveals a broader structural tension: sub-Saharan Africa must manage simultaneous epidemic risks—Ebola in the east, persistent cholera in several northern states—with strained health system capacity. Mobilizing the pharmaceutical supply chain as a first surveillance barrier signals the decentralized strategy Abuja intends to adopt against this emerging threat.